Last reviewed · How we verify
NM504:
At a glance
| Generic name | NM504: |
|---|---|
| Sponsor | NuMe Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin (EARLY_PHASE1)
- A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NM504: CI brief — competitive landscape report
- NM504: updates RSS · CI watch RSS
- NuMe Health portfolio CI